Back to Trades
Nolet Chris
DirectorCIK 0001782814
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, Nolet Chris, Director, has disclosed $430.5K in transactions — all concentrated in ArriVent BioPharma, Inc. (AVBP). Data is sourced from official SEC Form 3, 4, and 5 filings.